ICER Publishes Final Evidence Report on Gene Therapies for Sickle Cell Disease
August 22, 2023
August 22, 2023
BOSTON, Massachusetts, Aug. 22 (TNSres) -- The Institute for Clinical and Economic Review issued the following news release on Aug. 21, 2023:
* * *
* Despite uncertainty regarding longer-term outcomes, lovo-cel and exa-cel both estimated to produce substantial gains in length and quality of life; independent appraisal committee voted that currently available evidence is adequate to demonstrate a net health benefit over standard of care
* Current evidence su . . .
* * *
* Despite uncertainty regarding longer-term outcomes, lovo-cel and exa-cel both estimated to produce substantial gains in length and quality of life; independent appraisal committee voted that currently available evidence is adequate to demonstrate a net health benefit over standard of care
* Current evidence su . . .